About
Wiersma manages RCT's pharmaceutical and biologics patent estate, evaluates IP for investment opportunities, and oversees a portfolio of commercialized technologies. He has been involved in commercializing anticancer agents, radiopharmaceuticals, and the PSA prostate cancer blood test, with focus areas in biologics, diagnostics, oncology, and metabolic disease.
Contact· self-published, not guessed
Invests in
BiotechMedical Devices
Investments
Board seats
Alerion Biomedical Inc.MetaProbe Inc.
Per the firm's website.
Colleagues at Research Corporation Technologies
Avi Roop
Managing Director at Research Corporation Technologies
Brad Morie
Senior Director, Biotechnologies at Research Corporation Technologies
Chad W. Souvignier
Vice President at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies
Maggie Zhou
Associate Controller at Research Corporation Technologies
Frequently asked questions
- Who is David A. Wiersma?
- Wiersma manages RCT's pharmaceutical and biologics patent estate, evaluates IP for investment opportunities, and oversees a portfolio of commercialized technologies. He has been involved in commercializing anticancer agents, radiopharmaceuticals, and the PSA prostate cancer blood test, with focus areas in biologics, diagnostics, oncology, and metabolic disease.
- Where does David A. Wiersma work?
- David A. Wiersma is Senior Associate at Research Corporation Technologies.
- What does David A. Wiersma invest in?
- David A. Wiersma invests in Biotech, Medical Devices.
- What boards does David A. Wiersma sit on?
- David A. Wiersma holds tracked board seats at Alerion Biomedical Inc., MetaProbe Inc..